Loading clinical trials...
Loading clinical trials...
Phase IV, Multicenter, Open Label, Non Randomized Comparative Group Study to Assess the Safety and Performance of the OrbiSymm in Subjects Referred to Contra Lateral Breast Symmetrisation Following Breast Reconstruction Post Mastectomy
Conditions
Interventions
OrbiSymm device
Breast symmetrisation
Locations
1
Italy
Instituto Nazionale dei Tumori di Roma "Regina Elena"
Rome, Italy
Start Date
October 1, 2016
Primary Completion Date
October 1, 2019
Completion Date
October 1, 2019
Last Updated
September 29, 2016
Lead Sponsor
Orbix Medical Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions